Adam M Veness insider trades
Open-market stock purchases and sales by Adam M Veness, SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc /DE/, from SEC Form 4 filings since Jun 5, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 13, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.8M |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $356K |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $68.5K |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.3M |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.1M |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Feb 3, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |